Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 723.40
Bid: 723.00
Ask: 723.40
Change: -2.60 (-0.36%)
Spread: 0.40 (0.055%)
Open: 728.60
High: 731.20
Low: 721.00
Prev. Close: 726.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Accounting policy changes & UK bank levy guidance

6 Feb 2020 10:54

RNS Number : 2064C
Standard Chartered PLC
06 February 2020
 

 

Accounting policy changes & UK bank levy guidance

 

Changes to selected accounting policies

Standard Chartered PLC (the Group) has reviewed its accounting policies and is making the changes set out below. These will be reflected in the full-year 2019 disclosures, to be published on 27 February 2020, along with prior period comparatives changed to align with the new disclosures.

 

1. Net interest income and the calculation of net interest margin

The Group has changed its accounting policy for net interest income and net trading income (a component of 'other income' in the table below) to better reflect the underlying performance of its banking book. There is no change in total income, only a reclassification between net interest income and net trading income on the face of the income statement.

The revised accounting policy will result in the Group recognising all gains and losses from the trading book within trading income. As before, interest income and expense from the banking book positions will still be presented in net interest income. The instruments moving out of average interest earning assets include reverse repurchase agreements, bonds and loans. These instruments are held to service client demand and risk-managed on a mark-to-market basis.

With the reclassification of the components of gross income, it is necessary to adjust the interest expense included in the net interest margin calculation to remove funding costs for the trading book. As with the change in classification of net interest income, the new basis of preparation for the presentation of the Group's net interest margin will better reflect the underlying performance of the banking book.

The tables below show the Group's previously reported net interest margin and the net interest margin under the revised accounting policy and new basis of preparation:

 

As reported

On a statutory basis

$ millions

 FY 2018

1Q'19

2Q'19

3Q'19

Net interest income

8,793

2,256

2,362

2,369

Other income1

5,996

1,662

1,550

1,589

Statutory operating income

14,789

3,918

3,912

3,958

Average interest earning assets

558,135

585,408

584,135

602,798

Net interest margin (%)2

1.58

1.56

1.62

1.56

 

Memorandum: on an underlying basis

$ millions

 FY 2018

1Q'19

2Q'19

3Q'19

Net interest income

8,840

2,272

2,371

2,385

Other income1

6,128

1,541

1,512

1,593

Underlying operating income

14,968

3,813

3,883

3,978

 

 

 

 

 

As restated

On a statutory basis

$ millions

 FY2018

1Q'19

2Q'19

3Q'19

Net interest income

7,796

1,905

1,933

1,922

Other income1

6,993

2,013

1,979

2,036

Statutory operating income

14,789

3,918

3,912

3,958

Net interest income excluding funding costs for FVTPL portfolio

 

8,033

 

1,993

 

2,011

 

2,025

Average interest earning assets

476,114

487,424

484,066

499,260

Net interest margin (%)2

1.69

1.66

1.67

1.61

Memorandum: on an underlying basis

 

$ millions

 FY 2018

1Q'19

2Q'19

3Q'19

Net interest income

7,840

1,920

1,942

1,937

Other income1

7,128

1,893

1,941

2,041

Underlying operating income

14,968

3,813

3,883

3,978

1 Other income is made up of net trading income, net fees and commissions, and other operating income. In 2018, net trading income was c.40% of other income

2 Net interest margin is annualised net interest income (or net interest income, excluding funding costs for the FVTPL portfolio) divided by average interest earning assets

 

 

2. Change in recognition of interest in suspense with regard to Stage 3 assets

Historically, the Group recorded Stage 3 loans at their book value at the time of reclassification to Stage 3. No further interest was accrued after reclassification.

Following a clarification issued by the International Financial Reporting Interpretations Committee in March 2019, the Group is changing its accounting policy to report interest in suspense for stage 3 exposures.

Under the revised policy, interest will continue to accrue on Stage 3 loans together with an equivalent increase in impairment provisions. This change will have no effect on total profit. The interest income and impairment are netted together for income statement reporting purposes. This has been the case historically and will remain the case going forward.

However, the increase in historical impairment provisions will result in gross stage 3 assets increasing by approximately a fifth under the new accounting policy. Net stage 3 assets remain unchanged as the increase in gross stage 3 assets is offset by an increase in provisions.

If there are ultimately any recoveries on Stage 3 loans, any recoveries will now be recognised within the credit impairment line whereas previously the Group's approach was to recognise residual amounts in excess of credit provisions within interest income.

There will be no material net impact on the balance sheet or income statement.

Stage 3 cover ratios have increased as the interest in suspense is fully provided.

The tables below show the Group's previously reported credit risk disclosures and the effect of their restatement:

 

As reported

$ millions

31.12.18

 

Gross stage 3 assets

6,924

 

Stage 3 provisions

(4,056)

 

Net stage 3 assets

2,868

 

 

Cover ratio of stage 3 before collateral3

59%

 

Cover ratio of stage 3 after collateral4

81%

 

 

As restated

$ millions

31.12.18

Gross stage 3 assets

8,454

Stage 3 provisions

(5,586)

Net stage 3 assets

2,868

Cover ratio of stage 3 before collateral3

66%

Cover ratio of stage 3 after collateral4

85%

 

3 The ratio of stage 3 provisions compared to stage 3 gross assets

4 The ratio of stage 3 provisions and realisable value of collateral held against these assets compared to stage 3 gross assets

 

3. Income re-allocation due to internal reorganisation of the Corporate Finance and Lending & Portfolio Management business lines

The Group is also reclassifying income by product following an internal reorganisation of the Corporate Finance and Lending & Portfolio Management business lines. There is no change to total income, income by region or income by segment.

All simple lending-related businesses are now managed by coverage bankers within the Lending & Portfolio Management team while more complex event-driven transactions and transactions requiring specialist structuring knowledge remain managed within the Corporate Finance team.

The tables below show what the Group's previously reported income in these related product lines would have been on the new organisational basis:

 

As reported

$ millions

FY 2018

1Q'19

2Q'19

3Q'19

Corporate Finance

1,423

321

330

340

Lending

518

129

140

145

Sub-total

1,941

450

470

485

As restated

$ millions

 FY 2018

1Q'19

2Q'19

3Q'19

Corporate Finance

1,186

262

272

281

Lending

755

188

198

204

Sub-total

1,941

450

470

485

4. Updated guidance on UK bank levy

The Group's current expectation is that the UK bank levy for 2019 will be around $347 million (2018: $324 million). The levy applies to certain UK banks and the UK operations of foreign banks, and is payable each year based on a percentage of the chargeable equities and liabilities on the Group's consolidated balance sheet date.

 

For further information, please contact:

Mark Stride

Global Head, Investor Relations

+44 (0)20 7885 8596

mark.stride@sc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUPUUAPUPUGUQ
Date   Source Headline
14th Mar 20242:03 pmRNSTotal Voting Rights
14th Mar 202411:05 amRNSDirector/PDMR Shareholding
13th Mar 20246:02 pmRNSTransaction in Own Shares
13th Mar 20246:00 pmRNSPublication of Supplementary Prospectus
13th Mar 202411:26 amRNSOverseas Regulatory Announcement – Grant of awards
13th Mar 202410:45 amRNSDirector/PDMR Shareholding
12th Mar 20246:00 pmRNSTransaction in Own Shares
12th Mar 20242:54 pmRNSDirector/PDMR Shareholding
12th Mar 202410:57 amRNSOverseas Regulatory Announcement - Grant of awards
12th Mar 202410:00 amRNSStandard Chartered: Management Team Change
11th Mar 20246:23 pmRNSTransaction in Own Shares
8th Mar 20245:59 pmRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 202411:33 amRNSNotice of Redemption
5th Mar 20246:15 pmRNSTransaction in Own Shares
4th Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 20245:50 pmRNSTransaction in Own Shares
1st Mar 202412:00 pmRNSTotal Voting Rights
29th Feb 20246:15 pmRNSTransaction in Own Shares
29th Feb 20244:21 pmRNSPublication of Final Terms
29th Feb 20247:00 amRNSIssuance of U.S.$1bn Additional Tier 1 Securities
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20246:09 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSShare Buy-Back
23rd Feb 20242:39 pmRNSFull Year 2023 Pillar 3 Disclosures
23rd Feb 202412:13 pmRNSPublication of Supplementary Prospectus
23rd Feb 20247:00 amRNSAnnual Report 2023
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 2
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 1
23rd Feb 20247:00 amRNSSCPLC Final Results 2023
16th Feb 202410:00 amRNSDirectorate Changes
8th Feb 202411:07 amRNSOverseas Regulatory Announcement
1st Feb 202410:26 amRNSTotal Voting Rights
26th Jan 202412:28 pmRNSDirector/PDMR Shareholding
17th Jan 202412:33 pmRNSPublication of Final Terms
5th Jan 202412:04 pmRNSPublication of Final Terms
2nd Jan 20243:33 pmRNSTotal Voting Rights
28th Dec 202311:22 amRNSPublication of Supplementary Prospectus
27th Dec 202312:36 pmRNSNotice of Redemption
21st Dec 20231:00 pmRNSDirectorate Change
1st Dec 202311:56 amRNSBlock listing Interim Review
1st Dec 202310:37 amRNSTotal Voting Rights
29th Nov 20231:42 pmRNSSCPLC Sustainability Investor Event
22nd Nov 20239:17 amRNSOverseas Regulatory Announcement
21st Nov 202310:28 amRNSOverseas Regulatory Announcement - Grant of Awards
9th Nov 202310:01 amRNSNotice of Redemption
8th Nov 20239:00 amRNSNotice of Redemption
6th Nov 20236:30 pmRNSTransaction in Own Shares
3rd Nov 20236:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.